Journal of Medicinal Chemistry · 2019 · 25 citations · 28 references
PharmacyNeurosciencePharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsAllosteric Modulator DesignCholinergic NeurochemistryCholinergic PharmacologyPotency OptimizationAllosteric Modulator BindingCholinergic Receptor PharmacologyCognitive Enhancement By Cholinergic AgentsNicotinic Acetylcholine Receptor AgonismNicotinic Receptor PharmacologyNovel-object TestPositive Allosteric ModulationPositive Allosteric Modulators
has shown excellent safety profile in phase 1 clinical trials and is being evaluated for efficacy and safety as monotherapy in patients with mild to moderate Alzheimer's disease.
28
Philippe Séguéla, Jacques I. Wadiche, Kelly Dineley‐Miller et al. · Journal of Neuroscience · 1993 · 1.5K citations · Full text
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Ann Olincy, Josette G. Harris, Lynn Johnson et al. · Archives of General Psychiatry · 2006 · 526 citations
Medicine, Neuroscience, Pharmacology +17
Daniel B. Timmermann, Jens Halvard Grønlien, Kathy L. Kohlhaas et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 214 citations
Medicine, Neuroscience, Pharmacology +17